Rifampin-Resistant <em>Cutibacterium</em> (formerly <em>Propionibacterium</em>) <em>namnetense</em> Superinfection after <em>Staphylococcus aureus</em> Bone Infection Treatment
<p class="p p-first-last" id="__p2">After rifampin and levofloxacin treatment for a <em>Staphylococcus aureus</em> bone infection, a pyogenic granuloma due to a newly described <em>Cutibacterium</em> species,<em> C. namnetense</em> develo...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Copernicus Publications
2018-11-01
|
Series: | Journal of Bone and Joint Infection |
Online Access: | https://jbji.copernicus.org/articles/3/255/2018/jbji-3-255-2018.pdf |
id |
doaj-81924222deb341618707c9ef35dfc760 |
---|---|
record_format |
Article |
spelling |
doaj-81924222deb341618707c9ef35dfc7602021-03-03T14:48:15ZengCopernicus PublicationsJournal of Bone and Joint Infection2206-35522018-11-01325525710.7150/jbji.30029Rifampin-Resistant <em>Cutibacterium</em> (formerly <em>Propionibacterium</em>) <em>namnetense</em> Superinfection after <em>Staphylococcus aureus</em> Bone Infection TreatmentS. Corvec0S. Corvec1S. Corvec2A. Guillouzouic3G. G. Aubin4S. Touchais5S. Touchais6O. Grossi7O. Grossi8F. Gouin9F. Gouin10P. Bémer11P. Bémer12Service de Bactériologie-Hygiène hospitalière, CHU de Nantes, Nantes, FranceCRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, FranceNantes study group member of CRIOGO (Centre de Référence des Infections Ostéo-articulaires du Grand Ouest), Nantes, FranceService de Bactériologie-Hygiène hospitalière, CHU de Nantes, Nantes, FranceService de Bactériologie-Hygiène hospitalière, CHU de Nantes, Nantes, FranceNantes study group member of CRIOGO (Centre de Référence des Infections Ostéo-articulaires du Grand Ouest), Nantes, FranceClinique chirurgicale orthopédique et traumatique, CHU de Nantes, Nantes, France.Nantes study group member of CRIOGO (Centre de Référence des Infections Ostéo-articulaires du Grand Ouest), Nantes, FranceService de Maladies infectieuses, CHU de Nantes, Nantes, France - Département de Médecine Interne -Infectiologie, Nouvelles Cliniques Nantaises, Nantes, FranceNantes study group member of CRIOGO (Centre de Référence des Infections Ostéo-articulaires du Grand Ouest), Nantes, FranceClinique chirurgicale orthopédique et traumatique, CHU de Nantes, Nantes, France.Service de Bactériologie-Hygiène hospitalière, CHU de Nantes, Nantes, FranceNantes study group member of CRIOGO (Centre de Référence des Infections Ostéo-articulaires du Grand Ouest), Nantes, France<p class="p p-first-last" id="__p2">After rifampin and levofloxacin treatment for a <em>Staphylococcus aureus</em> bone infection, a pyogenic granuloma due to a newly described <em>Cutibacterium</em> species,<em> C. namnetense</em> developed on the tibia former external fixator. This rifampin resistant bacterium, selected during treatment, harbored a mutation in the <em>rpoB</em> gene. This case illustrates the possible <em>in vivo</em> selection of resistant mutant most likely due to the bacterial burden and therefore the importance of adequate bone infection treatment.</p>https://jbji.copernicus.org/articles/3/255/2018/jbji-3-255-2018.pdf |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
S. Corvec S. Corvec S. Corvec A. Guillouzouic G. G. Aubin S. Touchais S. Touchais O. Grossi O. Grossi F. Gouin F. Gouin P. Bémer P. Bémer |
spellingShingle |
S. Corvec S. Corvec S. Corvec A. Guillouzouic G. G. Aubin S. Touchais S. Touchais O. Grossi O. Grossi F. Gouin F. Gouin P. Bémer P. Bémer Rifampin-Resistant <em>Cutibacterium</em> (formerly <em>Propionibacterium</em>) <em>namnetense</em> Superinfection after <em>Staphylococcus aureus</em> Bone Infection Treatment Journal of Bone and Joint Infection |
author_facet |
S. Corvec S. Corvec S. Corvec A. Guillouzouic G. G. Aubin S. Touchais S. Touchais O. Grossi O. Grossi F. Gouin F. Gouin P. Bémer P. Bémer |
author_sort |
S. Corvec |
title |
Rifampin-Resistant <em>Cutibacterium</em> (formerly <em>Propionibacterium</em>) <em>namnetense</em> Superinfection after <em>Staphylococcus aureus</em> Bone Infection Treatment |
title_short |
Rifampin-Resistant <em>Cutibacterium</em> (formerly <em>Propionibacterium</em>) <em>namnetense</em> Superinfection after <em>Staphylococcus aureus</em> Bone Infection Treatment |
title_full |
Rifampin-Resistant <em>Cutibacterium</em> (formerly <em>Propionibacterium</em>) <em>namnetense</em> Superinfection after <em>Staphylococcus aureus</em> Bone Infection Treatment |
title_fullStr |
Rifampin-Resistant <em>Cutibacterium</em> (formerly <em>Propionibacterium</em>) <em>namnetense</em> Superinfection after <em>Staphylococcus aureus</em> Bone Infection Treatment |
title_full_unstemmed |
Rifampin-Resistant <em>Cutibacterium</em> (formerly <em>Propionibacterium</em>) <em>namnetense</em> Superinfection after <em>Staphylococcus aureus</em> Bone Infection Treatment |
title_sort |
rifampin-resistant <em>cutibacterium</em> (formerly <em>propionibacterium</em>) <em>namnetense</em> superinfection after <em>staphylococcus aureus</em> bone infection treatment |
publisher |
Copernicus Publications |
series |
Journal of Bone and Joint Infection |
issn |
2206-3552 |
publishDate |
2018-11-01 |
description |
<p class="p p-first-last" id="__p2">After rifampin and levofloxacin treatment for a <em>Staphylococcus aureus</em> bone infection, a pyogenic granuloma due to a newly described <em>Cutibacterium</em> species,<em> C. namnetense</em> developed on the tibia former external fixator. This rifampin resistant bacterium, selected during treatment, harbored a mutation in the <em>rpoB</em> gene. This case illustrates the possible <em>in vivo</em> selection of resistant mutant most likely due to the bacterial burden and therefore the importance of adequate bone infection treatment.</p> |
url |
https://jbji.copernicus.org/articles/3/255/2018/jbji-3-255-2018.pdf |
work_keys_str_mv |
AT scorvec rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment AT scorvec rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment AT scorvec rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment AT aguillouzouic rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment AT ggaubin rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment AT stouchais rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment AT stouchais rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment AT ogrossi rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment AT ogrossi rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment AT fgouin rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment AT fgouin rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment AT pbemer rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment AT pbemer rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment |
_version_ |
1724232801121730560 |